Form 4: Guardant Health CIO Reports Planned Stock Sale

Guardant Health's Chief Information Officer, Kumud Kalia, reported the sale of 2,000 shares of common stock for approximately $123,510.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc., reported a transaction involving the company's common stock.
• The transaction, a sale of 2,000 shares, occurred on August 21, 2025.
• The shares were sold at a price of $61.755 per share, totaling approximately $123,510.
• This sale was conducted pursuant to a Rule 10b5-1(c) pre-planned trading arrangement.
• Following this transaction, Ms. Kalia beneficially owns 18,500 shares of Guardant Health common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale, likely pre-planned under a Rule 10b5-1 arrangement, which typically has a neutral impact on sentiment as it is often for personal financial planning rather than a reflection of company prospects.

Negatives

• An insider sale of 2,000 shares by a key executive, though pre-planned, represents a reduction in direct ownership.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, which is generally not significant given the pre-planned nature of the sale and the relatively small volume compared to the company's total outstanding shares.

Key Dates

Keywords

Guardant Health, GH, Insider Trading, Form 4, Stock Sale, Kumud Kalia, Chief Information Officer, 10b5-1 Plan